drugset / Trial / NCT06977568

A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip

NCT06977568

Phase 2 Terminated 1 enrolled Pacira Pharmaceuticals, Inc
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to evaluate an injection procedure for the investigational drug in people with Osteoarthritis of the Hip. The Sponsor is conducting this research to evaluate successful injections in the hip by using two different needle sizes.

Timeline

Start
2025-07-25
Primary completion
2025-10-16
Completion
2025-10-16

Drugs

EvaluationDrugModalityDoseRoute
Comparator Triamcinolone Acetonide Other / unclassified 32 mg Other
Comparator Triamcinolone Acetonide Other / unclassified 40 mg Other

Indications